 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| W723871 | 6-chloro-4-(3,5-dimethylphenylamino)pyridazine-3-carboxamide | 1446792-66-0 | 95% |
| W723872 | 6-(2H-1,2,3-triazol-2-yl)pyridin-2-amine | 1429777-49-0 | 95% |
| W723873 | N2,N2,3-trimethylpyridine-2,6-diamine | 1602681-99-1 | 95% |
| W723874 | ethyl 6-chloro-4-(6-(dimethylamino)-5-methylpyridin-2-ylamino)pyridazine-3-carboxylate | 1602682-00-7 | 95% |
| W723875 | ethyl 4-(2-tert-butylpyrimidin-4-ylamino)-6-chloropyridazine-3-carboxylate | 1602682-05-2 | 95% |
| W723876 | 2-bromo-6-(2-methoxypropan-2-yl)pyridine | 1602682-09-6 | 95% |
| W723877 | 6-(2-methoxypropan-2-yl)pyridin-2-amine | 1602682-10-9 | 95% |
| W723878 | 2-(3-(benzyloxy)phenyl)propan-2-amine | 1196733-68-2 | 95% |
| W723879 | ethyl 4-(6-tert-butylpyridin-2-ylamino)-6-chloropyridazine-3-carboxylate | 1446792-21-7 | 95% |
| W723880 | (5-bromo-2-chlorophenyl)(4-fluorophenyl)methanone | 915095-85-1 | 95% |
| W723881 | 1-(1-benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-5,6-dimethyl-1,3-dihydro-benzoimidazol-2-one | 2147-82-2 | 95% |
| W723882 | 1-hydroxymethyl-3-piperidin-4-yl-1,3-dihydro-benzoimidazol-2-one | 58716-48-6 | 95% |
| W723883 | 1-[1-(4-oxo-4-phenyl-butyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one | 63959-22-8 | 95% |
| W723884 | 1-acetyl-3-piperidin-4-yl-1,3-dihydro-benzoimidazol-2-one | 2148-97-2 | 95% |
| W723885 | 1-(1-benzyl-1,2,3,6-tetrahydro-pyridin-4-yl)-3-hydroxymethyl-1,3-dihydro-benzoimidazol-2-one | 2148-98-3 | 95% |
| W723886 | 1-[1-(4-oxo-4-phenyl-butyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-1,3-dihydro-benzoimidazol-2-one | 2318-32-3 | 95% |
| W723887 | 1-[1-(4-oxo-4-thiophen-2-yl-butyl)-1,2,3,6-tetrahydro-pyridin-4-yl]-1,3-dihydro-benzoimidazol-2-one | 2587-41-9 | 95% |
| W723888 | 1-{1-[4-(4-chloro-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2147-93-5 | 95% |
| W723889 | 1-{1-[4-(4-ethyl-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2147-91-3 | 95% |
| W723890 | 1-[1-(4-oxo-4-p-tolyl-butyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one | 2318-35-6 | 95% |
| W723891 | 1-[1-(4-oxo-4-thiophen-2-yl-butyl)-piperidin-4-yl]-1,3-dihydro-benzoimidazol-2-one | 2064-54-2 | 95% |
| W723892 | 1-{1-[4-(4-isopropyl-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2147-90-2 | 95% |
| W723893 | 1-{1-[4-(4-bromo-phenyl)-4-oxo-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2293-15-4 | 95% |
| W723894 | 1-{1-[4-(3,4-dimethyl-phenyl)-4-oxo-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2064-53-1 | 95% |
| W723895 | 1-{1-[4-(4-ethyl-phenyl)-4-oxo-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2064-50-8 | 95% |
| W723896 | 1-{1-[4-(2,5-dimethyl-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2147-94-6 | 95% |
| W723897 | 1-{1-[4-(4-tert-butyl-phenyl)-4-oxo-butyl]-1,2,3,6-tetrahydro-pyridin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2147-89-9 | 95% |
| W723898 | 1-{1-[4-(4-isopropyl-phenyl)-4-oxo-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2064-51-9 | 95% |
| W723899 | 1-{1-[4-(4-methoxy-phenyl)-4-oxo-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2148-01-8 | 95% |
| W723900 | 1-{1-[4-(4-tert-butyl-phenyl)-4-oxo-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one | 2064-52-0 | 95% |
|
|
|
|
